Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""United States Food and Drug Administration"" wg kryterium: Temat


Tytuł :
Prescription medications for use in pregnancy-perspective from the US Food and Drug Administration.
Autorzy :
Wesley BD; Division of Urology, Obstetrics & Gynecology, US Food and Drug Administration, Silver Spring, MD. Electronic address: .
Sewell CA; Division of Urology, Obstetrics & Gynecology, US Food and Drug Administration, Silver Spring, MD.
Chang CY; Division of Urology, Obstetrics & Gynecology, US Food and Drug Administration, Silver Spring, MD.
Hatfield KP; Division of Urology, Obstetrics & Gynecology, US Food and Drug Administration, Silver Spring, MD.
Nguyen CP; Division of Urology, Obstetrics & Gynecology, US Food and Drug Administration, Silver Spring, MD.
Pokaż więcej
Źródło :
American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2021 Jul; Vol. 225 (1), pp. 21-32.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Approval*/legislation & jurisprudence
Drug Approval*/statistics & numerical data
Pregnancy*
Prescription Drugs*
United States Food and Drug Administration*
Animals ; Clinical Trials as Topic ; Female ; Fetus/drug effects ; Humans ; Lactation ; Pregnancy Complications/drug therapy ; Risk Assessment ; Teratogens ; United States
Czasopismo naukowe
Tytuł :
A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System.
Autorzy :
Cocoros NM; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Fuller CC; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Adimadhyam S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Ball R; US Food and Drug Administration, Silver Spring, Maryland, USA.
Brown JS; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Dal Pan GJ; US Food and Drug Administration, Silver Spring, Maryland, USA.
Kluberg SA; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Lo Re V 3rd; Division of Infectious Diseases, Department of Medicine, and Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Maro JC; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Nguyen M; US Food and Drug Administration, Silver Spring, Maryland, USA.
Orr R; US Food and Drug Administration, Silver Spring, Maryland, USA.
Paraoan D; US Food and Drug Administration, Silver Spring, Maryland, USA.
Perlin J; HCA Healthcare, Nashville, Tennessee, USA.
Poland RE; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.; HCA Healthcare, Nashville, Tennessee, USA.
Driscoll MR; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Sands K; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.; HCA Healthcare, Nashville, Tennessee, USA.
Toh S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Yih WK; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Platt R; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Pokaż więcej
Corporate Authors :
And the FDA-Sentinel COVID-19 Working Group
Źródło :
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2021 Jul; Vol. 30 (7), pp. 827-837. Date of Electronic Publication: 2021 Apr 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
COVID-19/*therapy
Health Information Management/*organization & administration
Product Surveillance, Postmarketing/*methods
Public Health Surveillance/*methods
United States Food and Drug Administration/*organization & administration
Antiviral Agents/therapeutic use ; COVID-19/epidemiology ; COVID-19/virology ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/adverse effects ; Communicable Disease Control/legislation & jurisprudence ; Databases, Factual/statistics & numerical data ; Electronic Health Records/statistics & numerical data ; Health Policy ; Humans ; Pandemics/prevention & control ; Pandemics/statistics & numerical data ; United States/epidemiology ; United States Food and Drug Administration/legislation & jurisprudence
Czasopismo naukowe
Tytuł :
An introduction to risk evaluation and mitigation strategies.
Autorzy :
Dohm J; Covington & Burling LLP, DC, United States.
Ji M; Covington & Burling LLP, DC, United States. Electronic address: .
Pokaż więcej
Źródło :
Contraception [Contraception] 2021 Jul; Vol. 104 (1), pp. 4-7. Date of Electronic Publication: 2021 Apr 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Approval*
Risk Evaluation and Mitigation*
United States Food and Drug Administration*
Abortifacient Agents, Steroidal ; Drug and Narcotic Control ; Humans ; Mifepristone ; United States
Czasopismo naukowe
Tytuł :
[Analysis on Work Idea of Medical Device Classification Dynamic Adjustment Mechanism in the United States].
Autorzy :
Zhang C; NationalInstitutes for Food and Drug Control, Beijing, 100050.
Zhou L; Guangdong Medical Devices Quality Surveillance and Test Institute, Guangzhou, 510663.
Wang Y; NationalInstitutes for Food and Drug Control, Beijing, 100050.
Tian L; NationalInstitutes for Food and Drug Control, Beijing, 100050.
Yu X; NationalInstitutes for Food and Drug Control, Beijing, 100050.
Ji X; National Center of Standards Evaluation, SAMR, Beijing, 100088. E-mail:.
Zhang H; NationalInstitutes for Food and Drug Control, Beijing, 100050.
Pokaż więcej
Źródło :
Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation [Zhongguo Yi Liao Qi Xie Za Zhi] 2021 Jun 08; Vol. 45 (3), pp. 315-320.
Typ publikacji :
Journal Article
MeSH Terms :
United States Food and Drug Administration*
China ; United States
Czasopismo naukowe
Tytuł :
Adverse events involving hallux metatarsophalangeal joint implants: Analysis of the United States Food and Drug Administration data from 2010 to 2018.
Autorzy :
Akoh CC; Duke University Medical Center, Box 2887, Durham, NC 27710, United States. Electronic address: .
Chen J; Duke University Medical Center, Box 2887, Durham, NC 27710, United States.
Kadakia R; Duke University Medical Center, Box 2887, Durham, NC 27710, United States.
Park YU; Department of Orthopedic Surgery, Ajou University Hospital, Ajou University School of Medicine, Suwon, Gyeonggido, Republic of Korea.
Kim H; Department of Orthopedic Surgery, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
Adams SB; Duke University Medical Center, Box 2887, Durham, NC 27710, United States.
Pokaż więcej
Źródło :
Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons [Foot Ankle Surg] 2021 Jun; Vol. 27 (4), pp. 381-388. Date of Electronic Publication: 2020 May 18.
Typ publikacji :
Journal Article
MeSH Terms :
Databases, Factual*
United States Food and Drug Administration*
Arthrodesis/*instrumentation
Arthroplasty, Replacement/*instrumentation
Hallux/*surgery
Hallux Rigidus/*surgery
Joint Prosthesis/*adverse effects
Metatarsophalangeal Joint/*surgery
Osteoarthritis/*surgery
Adult ; Aged ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Middle Aged ; Osteoarthritis/epidemiology ; Prosthesis Failure/etiology ; Prosthesis-Related Infections/etiology ; Treatment Outcome ; United States/epidemiology
Czasopismo naukowe
Tytuł :
"Dangling" Accelerated Approvals in Oncology.
Autorzy :
Beaver JA; From the Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD.
Pazdur R; From the Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD.
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 May 06; Vol. 384 (18), pp. e68. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Approval*
United States Food and Drug Administration*
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Agents/*therapeutic use
B7-H1 Antigen/*antagonists & inhibitors
Programmed Cell Death 1 Receptor/*antagonists & inhibitors
Clinical Trials as Topic ; Humans ; Medical Oncology ; United States
Czasopismo naukowe
Tytuł :
A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2020.
Autorzy :
Kayki-Mutlu G; Department of Pharmacology, Faculty of Pharmacy, Ankara University, Ankara, Turkey.
Michel MC; Department of Pharmacology, Johannes Gutenberg University, Langenbeckstr. 1, 55118, Mainz, Germany. .
Pokaż więcej
Źródło :
Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2021 May; Vol. 394 (5), pp. 839-852. Date of Electronic Publication: 2021 Apr 16.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19*
Drug Approval*
Pandemics*
United States Food and Drug Administration*
Pharmacology, Clinical/*trends
Animals ; Drug Discovery ; Humans ; United States
Czasopismo naukowe
Tytuł :
Aerosol barriers in pediatric anesthesiology: Clinical data supports FDA caution.
Autorzy :
Tighe NTG; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
McClain CD; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Vlassakova BG; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Cravero JP; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Peyton JM; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Kovatsis PG; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Park RS; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Stein ML; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Paediatric anaesthesia [Paediatr Anaesth] 2021 Apr; Vol. 31 (4), pp. 461-464. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :
Journal Article
MeSH Terms :
Pediatrics*
United States Food and Drug Administration*
Airway Management/*methods
Anesthesiology/*methods
COVID-19/*prevention & control
Infection Control/*methods
Adolescent ; Aerosols ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; SARS-CoV-2 ; United States
Czasopismo naukowe
Tytuł :
How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals.
Autorzy :
Wu E; Department of Electrical Engineering, Stanford University, Stanford, CA, USA.
Wu K; Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.
Daneshjou R; Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.; Department of Dermatology, Stanford University, Stanford, CA, USA.
Ouyang D; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Ho DE; Stanford Law School, Stanford University, Stanford, CA, USA.
Zou J; Department of Electrical Engineering, Stanford University, Stanford, CA, USA. .; Department of Biomedical Data Science, Stanford University, Stanford, CA, USA. .; Chan-Zuckerberg Biohub, San Francisco, CA, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Apr; Vol. 27 (4), pp. 582-584.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Artificial Intelligence*
Device Approval*
Equipment and Supplies*
United States Food and Drug Administration*
Algorithms ; Databases as Topic ; Humans ; United States
Czasopismo naukowe
Tytuł :
The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
Autorzy :
Sharfstein JM; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Goodman JL; Medicine and Infectious Diseases, Georgetown University, Washington, DC.
Borio L; In-Q-Tel, Arlington County, Virginia.
Pokaż więcej
Źródło :
JAMA [JAMA] 2021 Mar 23; Vol. 325 (12), pp. 1153-1154.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Vaccines*
Government Regulation*
United States Food and Drug Administration*
COVID-19/*prevention & control
Drug Approval ; Humans ; Public Opinion ; United States
Czasopismo naukowe
Tytuł :
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs.
Autorzy :
Tompa DR; Biomolecular Crystallography Laboratory, Department of Bioinformatics, School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur 613 401, Tamil Nadu, India.
Immanuel A; Biomolecular Crystallography Laboratory, Department of Bioinformatics, School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur 613 401, Tamil Nadu, India.
Srikanth S; Biomolecular Crystallography Laboratory, Department of Bioinformatics, School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur 613 401, Tamil Nadu, India.
Kadhirvel S; Biomolecular Crystallography Laboratory, Department of Bioinformatics, School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur 613 401, Tamil Nadu, India. Electronic address: .
Pokaż więcej
Źródło :
International journal of biological macromolecules [Int J Biol Macromol] 2021 Mar 01; Vol. 172, pp. 524-541. Date of Electronic Publication: 2021 Jan 14.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Approval*
United States Food and Drug Administration*
Antiviral Agents/*therapeutic use
Virus Diseases/*drug therapy
Humans ; Pandemics ; United States ; Virus Diseases/epidemiology
Czasopismo naukowe
Tytuł :
Participation of Black US Residents in Clinical Trials of 24 Cardiovascular Drugs Granted FDA Approval, 2006-2020.
Autorzy :
Chen S; Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li J; Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2021 Mar 01; Vol. 4 (3), pp. e212640. Date of Electronic Publication: 2021 Mar 01.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
African Americans*
Clinical Trials as Topic*
Drug Approval*
United States Food and Drug Administration*
Cardiovascular Agents/*pharmacology
Cardiovascular Diseases/*drug therapy
Cardiovascular Diseases/ethnology ; Cross-Sectional Studies ; Humans ; Retrospective Studies ; United States/epidemiology
Czasopismo naukowe
Tytuł :
FDA Experience With Regulation of Naloxone Products to Address the Opioid Crisis and Opportunities for Leveraging Scientific Engagement.
Autorzy :
Amur S; Science and Research Team, Office of Translational Sciences, Center for Drug Evaluation and Research, US, Food and Drug Administration, Silver Spring, Maryland, USA.
Xu Y; Division of Neuropsychiatric Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Hertz S; Hertz and Fields Consulting, Inc., Silver Spring, Maryland, USA.; Division of Anesthesia, Addiction Medicine and Pain Medicine (DAAP), Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Clingman C; Strategic Partnerships, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Mar; Vol. 109 (3), pp. 569-572. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Approval*
Opioid Epidemic*
Research Personnel*
United States Food and Drug Administration*
Drug Overdose/*drug therapy
Naloxone/*therapeutic use
Narcotic Antagonists/*therapeutic use
Opioid-Related Disorders/*complications
Career Mobility ; Cooperative Behavior ; Drug Compounding ; Drug Overdose/etiology ; Humans ; Interinstitutional Relations ; Naloxone/adverse effects ; Narcotic Antagonists/adverse effects ; Staff Development ; Stakeholder Participation ; United States
Czasopismo naukowe
Tytuł :
Communicating Effectively About Emergency Use Authorization and Vaccines in the COVID-19 Pandemic.
Autorzy :
Quinn SC; Sandra Crouse Quinn is with the Department of Family Science and the Maryland Center for Health Equity, School of Public Health, University of Maryland, College Park. Amelia M. Jamison is with the Maryland Center for Health Equity, School of Public Health, University of Maryland. Vicki Freimuth is with Center for Health and Risk Communication (Emeritus), University of Georgia, Athens.
Jamison AM; Sandra Crouse Quinn is with the Department of Family Science and the Maryland Center for Health Equity, School of Public Health, University of Maryland, College Park. Amelia M. Jamison is with the Maryland Center for Health Equity, School of Public Health, University of Maryland. Vicki Freimuth is with Center for Health and Risk Communication (Emeritus), University of Georgia, Athens.
Freimuth V; Sandra Crouse Quinn is with the Department of Family Science and the Maryland Center for Health Equity, School of Public Health, University of Maryland, College Park. Amelia M. Jamison is with the Maryland Center for Health Equity, School of Public Health, University of Maryland. Vicki Freimuth is with Center for Health and Risk Communication (Emeritus), University of Georgia, Athens.
Pokaż więcej
Źródło :
American journal of public health [Am J Public Health] 2021 Mar; Vol. 111 (3), pp. 355-358. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19/*epidemiology
COVID-19/*prevention & control
COVID-19 Vaccines/*supply & distribution
Health Communication/*methods
United States Food and Drug Administration/*organization & administration
Cultural Competency ; Health Communication/standards ; Humans ; Pandemics ; SARS-CoV-2 ; Trust ; United States ; United States Food and Drug Administration/standards
Czasopismo naukowe
Tytuł :
US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.
Autorzy :
Dal-Ré R; Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Feb 22; Vol. 39 (8), pp. 1180-1182. Date of Electronic Publication: 2021 Jan 20.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Vaccines*
United States Food and Drug Administration*
COVID-19/*prevention & control
Drug Approval/*methods
Randomized Controlled Trials as Topic/*standards
Clinical Trials, Phase III as Topic ; Humans ; Randomized Controlled Trials as Topic/ethics ; United States
Czasopismo naukowe
Tytuł :
The FDA's Experience with Covid-19 Antibody Tests.
Autorzy :
Shuren J; From the Food and Drug Administration, Silver Spring, MD.
Stenzel T; From the Food and Drug Administration, Silver Spring, MD.
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Feb 18; Vol. 384 (7), pp. 592-594. Date of Electronic Publication: 2021 Feb 13.
Typ publikacji :
Journal Article
MeSH Terms :
Diagnostic Test Approval*/legislation & jurisprudence
Government Regulation*
United States Food and Drug Administration*/organization & administration
COVID-19 Serological Testing/*standards
Marketing of Health Services/*legislation & jurisprudence
Clinical Laboratory Techniques/standards ; Federal Government ; Humans ; Laboratories/legislation & jurisprudence ; Laboratories/standards ; Organizational Policy ; United States
Czasopismo naukowe
Tytuł :
Examination of patient characteristics and hydroxychloroquine use based on the US Food and Drug Administration's recommendation: a cross-sectional analysis in New York.
Autorzy :
Kim EJ; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York, USA.; Institute of Health Innovations and Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
Coppa K; Department of Information Services, Northwell Health, New Hyde Park, New York, USA.
Hirsch JS; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York, USA.; Institute of Health Innovations and Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.; Department of Information Services, Northwell Health, New Hyde Park, New York, USA.
Abrahams S; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York, USA.
Johnson J; Institute of Health Innovations and Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
Lesser M; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York, USA.; Institute of Health Innovations and Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.; Biostatistics Unit, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
Davidson KW; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York, USA.; Institute of Health Innovations and Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
Conigliaro J; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York, USA .; Institute of Health Innovations and Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
Pokaż więcej
Corporate Authors :
Northwell Health COVID-19 Research Consortium
Northwell Health COVID-19 Research Consortium
Źródło :
BMJ open [BMJ Open] 2021 Feb 08; Vol. 11 (2), pp. e042965. Date of Electronic Publication: 2021 Feb 08.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
United States Food and Drug Administration*
COVID-19/*drug therapy
Hydroxychloroquine/*administration & dosage
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Cross-Sectional Studies ; Female ; Humans ; Hydroxychloroquine/adverse effects ; Male ; Medicare ; Middle Aged ; New York ; Propensity Score ; Retrospective Studies ; United States ; Young Adult
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
The FDA's patient-focused drug development initiative.
Autorzy :
Kluetz PG; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD.
Bhatnagar V; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD.
Pokaż więcej
Źródło :
Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2021 Feb; Vol. 19 (2), pp. 70-72.
Typ publikacji :
Interview
MeSH Terms :
United States Food and Drug Administration*/organization & administration
Antineoplastic Agents/*therapeutic use
Drug Development/*organization & administration
Patient-Centered Care/*organization & administration
Clinical Trials as Topic/methods ; Congresses as Topic ; Drug Industry ; Health Policy ; Humans ; Intersectoral Collaboration ; Medical Oncology ; Neoplasms/drug therapy ; Neoplasms/psychology ; Patient Advocacy ; Patient Preference ; United States

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies